2m 2m 2m 2m 2m 2m 2m
Neurocrine Biosc (NBIX)
NASDAQ
$174.09-$0.010 (-0.006%)
Price as of Jul 13, 2026 7:40 PM EDT- $17.8BMarket Cap
- 28.84%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Neurocrine Biosc (NBIX)
$174.09-$0.010 (-0.006%)
NBIX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $174.10 | ||
Change | -$3.01 (-1.70%) | ||
Open | $174.50 | ||
High | $175.88 | ||
Low | $172.03 | ||
Previous Close | $177.11 | ||
Volume | 1,573,201 | ||
30-Day Average Volume | 1,243,691 | ||
1-Week Change | 0.00% | ||
1-Month Change | 8.98% | ||
1-Year Change | 28.84% | ||
3-Year Change | 81.30% | ||
5-Year Change | 79.10% | ||
Fundamentals | |||
Shares Outstanding | 100.5M | ||
Total Assets | $4.9B | ||
Market Cap | $17.8B | ||
Enterprise Value | $17.5B | ||
Period: QTR TTM FY | |||
Revenue | $811.0M | ||
Net Income | $197.9M | ||
Free Cash Flow | $136.7M | ||
EBIT | $246.8M | ||
EBITDA | $246.9M | ||
Net Working Capital | $1.6B | ||
EPS | $1.91 | ||
Enterprise Value/EBITDA | 71 | ||
Enterprise Value/Revenue | 22 | ||
P/B | 5 | ||
P/E | 93 | ||
PEG | 3 | ||
Price/Free Cash Flow | 130 | ||
Price/Operating Cash Flow | 122 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue